Biomed Industries, Inc. Announces Two NA-931 Phase 3 Trials, Targeting Durable Weight Loss & Lean-Mass Preservation ...
BioMed Realty Trust continues to push the life sciences conversion wave in Boston, quietly taking over two prominent development sites. The Blackstone-backed life sciences investor has entered a ...
CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, Feb. 4, 2026 /PRNewswire/ -- Harbour BioMed (the 'Company'; HKEX: ...
FDA has granted breakthrough device designation (BDD) for Orchestra BioMed's atrioventricular interval modulation (AVIM) therapy. Specifically, the designation is for an implantable device designed to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results